Zobrazeno 1 - 10
of 276
pro vyhledávání: '"C Dahlöf"'
Autor:
C Dahlöf
Publikováno v:
Cephalalgia. 21:791-795
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b39df5c81e94e73c0f8c4e6cfe37c4cf
https://doi.org/10.1046/j.1468-2982.2001.00256.x
https://doi.org/10.1046/j.1468-2982.2001.00256.x
Publikováno v:
Cephalalgia. 21:664-671
A randomly selected sample of 1668 individuals (782 women and 886 men) aged 18–74 years was interviewed by telephone using a standardized questionnaire including the International Headache Society (IHS) criteria for migraine. The survey was perform
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63cf1a5815c76c89c31cff2b35e0af45
https://doi.org/10.1046/j.1468-2982.2001.00218.x
https://doi.org/10.1046/j.1468-2982.2001.00218.x
Autor:
C Dahlöf
Publikováno v:
Cephalalgia. 19:769-778
Sumatriptan nasal spray is a single-dose device that delivers 5 mg, 10 mg, or 20 mg of sumatriptan (dosage availability dependent upon country) in a 0.1 ml aqueous solution to one nostril. The efficacy and tolerability of sumatriptan nasal spray have
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7db9ba60eab7aa15c075742e3745ba4
https://doi.org/10.1046/j.1468-2982.1999.1909769.x
https://doi.org/10.1046/j.1468-2982.1999.1909769.x
Autor:
R. Dawson, V. Lüben, J. M. Warter, C. Dahlöf, D. Noronha, E. Ashford, Nils Erik Gilhus, R. Salonen
Publikováno v:
Journal of Neurology. 241:463-469
Two double-blind, placebo-controlled, randomised, multicenter, multinational, parallel-group studies were carried out to identify the optimum dose of intranasal sumatriptan for the acute treatment of migraine. Study medication was taken as a single d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aa80c1508af758c09f5627827db82a83
https://doi.org/10.1007/bf00919706
https://doi.org/10.1007/bf00919706
Autor:
C Dahlöf, R Björkman
Publikováno v:
Cephalalgia. 13:117-123
The aim of the present study was to assess the efficacy and tolerability of single oral doses of 50 mg and 100 mg of diclofenac-K compared to placebo in migraine sufferers during three attacks. The study was conducted in a double-blind, randomized, p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e86eaad54f6685015adfd10ad82f598c
https://doi.org/10.1046/j.1468-2982.1993.1302117.x
https://doi.org/10.1046/j.1468-2982.1993.1302117.x
Autor:
E. Dimenäs, C. Dahlöf
Publikováno v:
European Journal of Clinical Pharmacology. 43:375-379
Two randomised, double-blind, cross-over studies in healthy volunteers given captopril 50 mg b.d. (n = 37; Study I) or enalapril 20 mg o.d. (n = 40; Study 2) and placebo for 2 weeks have been done to examine general well-being. Subjective experiences
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63c5a3e573b5b4e534c110d20ef5d9a8
https://doi.org/10.1007/bf02220612
https://doi.org/10.1007/bf02220612
Publikováno v:
Cephalalgia. 12:214-220
The efficacy of subcutaneous injection of sumatriptan in the acute treatment of migraine was assessed in a double-blind, randomized, placebo-controlled cross-over study of 27 migraine patients. In addition, the patients were asked to give information
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2325180143c89922722fd7795603eb8
https://doi.org/10.1046/j.1468-2982.1992.1204214.x
https://doi.org/10.1046/j.1468-2982.1992.1204214.x
Publikováno v:
European Journal of Clinical Pharmacology. 40:453-460
General well-being, adverse effects and anti-hypertensive efficacy have been investigated in a double blind, parallel-group, dose-response multicentre study of diltiazem and metoprolol monotherapy for hypertension. 128 patients with primary hypertens
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5b58e817ddb1b42f32ff716d185cb791
https://doi.org/10.1007/bf00315222
https://doi.org/10.1007/bf00315222
Autor:
J E, Hardebo, C, Dahlöf
Publikováno v:
Cephalalgia. 18:487-489
Subcutaneous injection of sumatriptan is an effective treatment for attacks of cluster headache with a short onset of action. This open, randomized study evaluates whether sumatriptan nasal spray at its highest commercially available dose (20 mg/dose
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::998fd9b3eb00dc6d2ed6afdd49c8aa44
https://doi.org/10.1046/j.1468-2982.1998.1807487.x
https://doi.org/10.1046/j.1468-2982.1998.1807487.x